２０２２年
- Comparison of two families with and without ataxia harboring novel variants in PRKCG
- Tada Y, Kume K, Noguchi S, Sekiya T, Nishinaka K, Ishiguchi H, Koh J, Emori S, Nakayama Y, Kurashige T, Izumi Y, Ito H, Sakai N, Kawakami H.
Journal of Human Genetics. 28 Jun 2022. doi: 10.1038/s10038-022-01057-6.
- Probable progressive supranuclear palsy in a patient with chronic schizophrenia: A case report.
- Kita A, Tsuji T, Koh J, Takahashi S, Yamamoto M, Sakamoto Y, Itogawa H, Kimoto S.
Experimental and Therapeutic Medicine. 2022 Jun. doi: 10.3892/etm.2022.11411
- Late-Onset Dyskinesia Occurring During Antipsychotic Treatment for Schizophrenia: Management of Tardive Dyskinesia Based on the Latest Knowledge
- Sakata M, Ito H.
Brain Nerve. 2022 May;74(5):571-574.
- Acute eye movement-retained internal ophthalmoplegia in atypical Miller Fisher syndrome variants are associated with IgG anti-GQ1b antibodies.
- Murakami K, Miyamoto K, Terayama A, Yoshikawa K, Kuwahara M, Ito H.
Journal of Neuroimmunology 2022;368:577880
- Acute Oropharyngeal Palsy following Bilateral Adie’s Tonic Pupils Associated with anti-GT1a and GQ1b IgG Antibodies.
- Murakami K, Kajimoto Y, Ito H.
Intern Med. 2022 Apr 2. doi: 10.2169/internalmedicine.8416-21.
- Validation of the Japanese version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease-Rating Scale (QUIP-RS).
- Takahashi M, Koh J, Yorozu S, Kajimoto Y, Nakayama Y, Sakata M, Yasui M, Hiwatani Y, Weintraub D, Ito H.
Parkinsons Dis. 2022 Mar 23;2022:1503167. doi: 10.1155/2022/1503167
- Efficacy and safety of istradefylline in patients with Parkinson's disease presenting with postural abnormalities: Results from a multicenter, prospective, and open-label exploratory study in Japan
- Takahashi M, Shimokawa T, Koh J, Takeshima T, Yamashita H, Kajimoto Y, Mori A, Ito H.
J Neurol Sci. 2022 Jan 15;432:120078. doi: 10.1016/j.jns.2021.120078.
- A single-arm open-label pilot study of brief mindfulness meditation to control impulsivity in Parkinson’s disease
- Koh J, Takahashi M, Ohmae Y, Taruya J, Sakata M, Yasui M, Terada M, Ito H. PLoSOne. 2022 Apr 6;17(4):e0266354. doi: 10.1371/journal.pone.0266354.
- Schizophrenia after remission of anti-NMDA receptor encephalitis.
- Yasuda K, Uenishi S, Sakamoto H, Hori K, Koh J, Takahashi S.
Asian J Psychiatr. 12;70:103027, 2022
- A case of anti-MOG antibody-positive ADEM following COVID-19 mRNA vaccination
- Mi
